Utility of the pareidolia test in mild cognitive impairment with Lewy bodies and Alzheimer's disease.

Calum Alexander Hamilton Fiona E Matthews Louise M AllanSally BarkerJoanna Ciafone Paul C Donaghy Rory Durcan Michael J FirbankSarah LawleyJohn Tiernan O'Brien Gemma Roberts John Paul Taylor Alan J Thomas

Published in: International journal of geriatric psychiatry (2021)

Whilst pareidolic responses are specifically more frequent in MCI-LB than MCI-AD, sensitivity of the pareidolia test is poorer than in DLB, with fewer patients manifesting VH at the earlier MCI stage. However, the high specificity and ease of use may make it useful in specialist clinics where imaging biomarkers are not available.

Keyphrases

mild cognitive impairment
cognitive decline
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
primary care
peritoneal dialysis
high resolution
prognostic factors
patient reported outcomes
mass spectrometry
photodynamic therapy